While Bio-Techne has lagged behind the broader market over the past year, Wall Street analysts maintain a moderately ...

Shares of Bio-Techne Corp. TECH advanced 1.43% to $47.37 Thursday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index SPX rising 0.17% to 7,445.72 ...

Life sciences company Bio-Techne (NASDAQ:TECH) fell short of the market’s revenue expectations in Q1 CY2026, with sales falling 1.5% year on year to $311.4 million. Its non-GAAP profit of $0.53 per ...

Baron Capital, an investment management company, released its Q1 2026 investor letter for the “Baron Asset Fund”. A copy of ...

Use of Non-GAAP Financial Measures: This press release contains financial measures that have not been calculated in accordance with accounting principles generally accepted in the U.S. (GAAP). We ...

My name is Mike Ryskin. I'm on the Bank of America Life Science Tools and Diagnostics team, and we're excited to be joined by Bio-Techne. We're pleased to host Kim Kelderman, Chief Executive Officer; ...

Bio-Techne Corporation (NASDAQ: TECH) announced that its Board of Directors has decided to pay a dividend of $0.08 per share for the quarter ended March 31, 2026. The quarterly dividend will be ...

Bio-Techne Corporation's ( NASDAQ:TECH ) earnings announcement last week didn't impress shareholders. However, ...

Shares of Bio-Techne Corp. TECH advanced 7.39% to $50.91 Thursday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index SPX falling 0.38% to 7,337.11 ...

Detailed price information for Billiontoone Inc Cl A (BLLN-Q) from The Globe and Mail including charting and trades.